Annual Drug Patent Expirations for JATENZO
Jatenzo is a drug marketed by Tolmar and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug.
Drug patent litigation for JATENZO.
This drug has twenty-five patent family members in twelve countries.
The generic ingredient in JATENZO is testosterone undecanoate. One supplier is listed for this compound. Additional details are available on the testosterone undecanoate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com